BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26632699)

  • 1. Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk.
    Li HG; Liu FF; Zhu HQ; Zhou X; Lu J; Chang H; Hu JH
    Medicine (Baltimore); 2015 Nov; 94(47):e2019. PubMed ID: 26632699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.
    Singal AG; Manjunath H; Yopp AC; Beg MS; Marrero JA; Gopal P; Waljee AK
    Am J Gastroenterol; 2014 Mar; 109(3):325-34. PubMed ID: 24445574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
    Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL
    PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.
    Salameh H; Raff E; Erwin A; Seth D; Nischalke HD; Falleti E; Burza MA; Leathert J; Romeo S; Molinaro A; Corradini SG; Toniutto P; Spengler U; Daly A; Day CP; Kuo YF; Singal AK
    Am J Gastroenterol; 2015 Jun; 110(6):846-56. PubMed ID: 25964223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.
    Ezzikouri S; Alaoui R; Tazi S; Nadir S; Elmdaghri N; Pineau P; Benjelloun S
    Infect Genet Evol; 2014 Jan; 21():179-83. PubMed ID: 24269995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 I148M polymorphism and progressive liver disease.
    Dongiovanni P; Donati B; Fares R; Lombardi R; Mancina RM; Romeo S; Valenti L
    World J Gastroenterol; 2013 Nov; 19(41):6969-78. PubMed ID: 24222941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
    Yang J; Trépo E; Nahon P; Cao Q; Moreno C; Letouzé E; Imbeaud S; Gustot T; Deviere J; Debette S; Amouyel P; Bioulac-Sage P; Calderaro J; Ganne-Carrié N; Laurent A; Blanc JF; Guyot E; Sutton A; Ziol M; Zucman-Rossi J; Nault JC
    Int J Cancer; 2019 Feb; 144(3):533-544. PubMed ID: 30289982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
    Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
    Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
    Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
    Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum adiponectin levels may be associated with the pathogenesis of hepatocellular carcinoma.
    Song RR; Gu XL
    Tumour Biol; 2015 Apr; 36(4):2983-92. PubMed ID: 25492487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.
    Yen YH; Tsai MC; Wu CK; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tseng PL; Lin MT; Huang CM; Lin JT; Hu TH
    J Formos Med Assoc; 2018 Sep; 117(9):833-840. PubMed ID: 29089161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between
    Huang Z; Guo X; Zhang G; Liang L; Nong B
    Int J Biol Markers; 2019 Jun; 34(2):117-122. PubMed ID: 30852978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
    Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
    Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.